Catalogo dei prodotti della ricerca

MAZZOTTA, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 868
EU - Europa 578
AS - Asia 140
AF - Africa 9
SA - Sud America 1
Totale 1.596
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 860
SE - Svezia 313
IT - Italia 145
IN - India 63
SG - Singapore 48
DE - Germania 30
FI - Finlandia 25
GB - Regno Unito 19
CN - Cina 15
BG - Bulgaria 12
RO - Romania 10
TG - Togo 8
IE - Irlanda 7
IR - Iran 7
CA - Canada 6
UA - Ucraina 5
FR - Francia 4
HK - Hong Kong 4
NL - Olanda 3
CH - Svizzera 2
JO - Giordania 2
MX - Messico 2
AR - Argentina 1
BE - Belgio 1
EE - Estonia 1
KZ - Kazakistan 1
PL - Polonia 1
ZA - Sudafrica 1
Totale 1.596
Salva come PNG Salva come JPEG
Città #
Stockholm 174
Fairfield 137
Ashburn 69
Chandler 67
Seattle 61
Woodbridge 61
Houston 55
Wilmington 51
Cambridge 48
Rome 44
Princeton 30
San Paolo di Civitate 26
Helsinki 23
Ann Arbor 19
Sacramento 16
Singapore 16
Andover 15
Lawrence 15
Millbury 15
New York 14
Boston 12
Bremen 12
Sofia 12
Dearborn 11
San Diego 11
Milan 10
Lomé 8
Norwalk 8
Surrey 7
Beijing 6
Padova 6
Dublin 5
Toronto 4
Bühl 3
Glasgow 3
Leawood 3
Mannheim 3
Phoenix 3
Plano 3
Ponte San Pietro 3
Zanjan 3
Amman 2
Birmingham 2
Boardman 2
Central 2
Formello 2
Frankfurt am Main 2
Fremont 2
Groningen 2
Hong Kong 2
Kashan 2
Magenta 2
Ottawa 2
Santa Maria Capua Vetere 2
Torino 2
Almaty 1
Augusta 1
Balasore 1
Bern 1
Carlentini 1
Chieti 1
Corridonia 1
Des Moines 1
Edinburgh 1
Falkenstein 1
Falls Church 1
Federal 1
Fuzhou 1
Guangzhou 1
Guidonia 1
Guidonia Montecelio 1
Hefei 1
Jacksonville 1
Kish 1
Kraainem 1
Levallois-perret 1
Liverpool 1
Locorotondo 1
London 1
Los Angeles 1
Menlo Park 1
Mexico City 1
Muizenberg 1
Nanchang 1
Nanjing 1
Prescot 1
Pune 1
Redwood City 1
Shanghai 1
Southend 1
Springfield 1
Tallinn 1
Trumbull 1
Vigonza 1
Zhengzhou 1
Totale 1.160
Salva come PNG Salva come JPEG
Nome #
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial 182
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 103
A nomogram to predict survival in non-small cell lung cancer patients treated with nivolumab 99
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 94
Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer 89
Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab 85
Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting 68
Is there a place for crizotinib in c-MET alterations? A case of efficacy in ALK positive NSCLC patient with secondary c-MET amplification 58
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden 57
KEAP1 and TP53 frame genomic, evolutionary and immunological subtypes of lung adenocarcinoma with different sensitivity to immunotherapy 56
Immunotherapy in HER2-positive breast cancer. state of the art and future perspectives 53
Neoadjuvant immune-checkpoint blockade in triple-negative breast cancer: current evidence and literature-based meta-analysis of randomized trials 52
null 50
null 50
null 50
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes 48
Palliative- and non-palliative indications for glucocorticoids use in course of immune-checkpoint inhibition. Current evidence and future perspectives 47
Role of chemotherapy in vulvar cancers: time to rethink standard of care? 47
Unexpected long survival of brain oligometastatic non-small cell lung cancer (NSCLC) treated with multimodal treatment: A single-center experience and review of the literature 44
CDKN2A/B gene loss and MDM2 alteration as a potential molecular signature for hyperprogressive disease in advanced NSCLC: A next-generation-sequencing approach 44
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting. a survey about Italian physicians’ practice 43
COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience 39
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 34
Observational multicenter study on the prognostic relevance of coagulation activation in risk assessment and stratification in locally advanced breast cancer. Outline of the arias trial 33
Circulating hpv dna in the management of oropharyngeal and cervical cancers: current knowledge and future perspectives 29
KEAP1-NFE2L2 Mutations in NSCLC: Increased Awareness Needed. Reply to “KEAP1-NFE2L2–Mutant NSCLC and Immune Checkpoint Inhibitors: A Large Database Analysis” 26
null 21
The use of fentanyl in pain management in head and neck cancer patients. a narrative review 20
Prognostic relevance of neutrophil to lymphocyte ratio (Nlr) in luminal breast cancer: A retrospective analysis in the neoadjuvant setting 19
Burnout of health care providers during the covid-19 pandemic: Focus on medical oncologists 19
Neoadjuvant endocrine therapy in breast cancer. Current knowledge and future perspectives 18
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study 15
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer 15
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma 13
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors 12
Complete Tumor Response with Afatinib 20 mg Daily in EGFR-Mutated Non-small Cell Lung Cancer: A Case Report 11
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study 11
Pulmonary Fibrosis after Pegylated Liposomal Doxorubicin in Elderly Patient with Cutaneous Angiosarcoma 5
Totale 1.759
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.756
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.756
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020290 0 8 28 19 35 42 36 29 32 32 15 14
2020/2021202 21 7 6 11 5 5 12 31 13 69 20 2
2021/2022361 5 4 11 20 75 31 3 28 20 19 97 48
2022/2023449 101 91 38 30 59 37 14 30 26 6 13 4
2023/2024209 7 24 3 15 23 36 19 26 3 23 19 11
2024/2025183 174 9 0 0 0 0 0 0 0 0 0 0
Totale 1.759